Literature DB >> 25545626

Voluntary organ donation system adapted to Chinese cultural values and social reality.

Jiefu Huang1, J Michael Millis, Yilei Mao, M Andrew Millis, Xinting Sang, Shouxian Zhong.   

Abstract

Organ donation and transplant systems have unique characteristics based on the local culture and socioeconomic context. China's transplant and organ donation systems developed without regulatory oversight until 2006 when regulation and policy were developed and then implemented over the next several years. Most recently, the pilot project of establishing a voluntary citizen-based deceased donor program was established. The pilot program addressed the legal, financial, and cultural barriers to organ donation in China. The pilot program has evolved into a national program. Significantly, it established a uniquely Chinese donor classification system. The Chinese donor classification system recognizes donation after brain death (category I), donation after circulatory death (category II), and donation after brain death followed by circulatory death (category III). Through August 2014, the system has identified 2326 donors and provided 6416 organs that have been allocated though a transparent organ allocation system. The estimated number of donors in 2014 is 1147. As China's attitudes toward organ donation have matured and evolved and as China, as a nation, is taking its place on the world stage, it is recognizing that its past practice of using organs from executed prisoners is not sustainable. It is time to recognize that the efforts to regulate transplantation and provide voluntary citizen-based deceased organ donation have been successful and that China should use this system to provide organs for all transplants in every province and hospital in China. At the national organ transplant congress on October 30, 2014, the Chairman of the China's national organ donation and transplantation committee, Jeifu Huang required all hospitals to stop using organs from executed prisoners immediately and the civilian organ donation will be sole source for organ transplant in China starting January 2015.
© 2015 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2015        PMID: 25545626     DOI: 10.1002/lt.24069

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  27 in total

1.  Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China.

Authors:  Hui Zhang; Chao Zhang; Sufen Zhu; Hongjian Ye; Donglan Zhang
Journal:  BMC Health Serv Res       Date:  2020-02-14       Impact factor: 2.655

2.  Use of donor-specific red blood cell transfusions for patients undergoing liver transplantation during the COVID-19 pandemic.

Authors:  Tao Lv; Xi Xu; Jiulin Song; Yifei Tan; Li Jiang; Jian Yang; Diao He; Lingxiang Kong; Weiyi Zhang; Panyu Chen; Qiwen Xiang; Tao Zhu; Hong Wu; Tianfu Wen; Jiayin Yang
Journal:  Hepatobiliary Surg Nutr       Date:  2021-08       Impact factor: 7.293

Review 3.  The Willingness to Donate Organs in Medical Students From an International Perspective: A Meta-Analysis.

Authors:  Marina Iniesta-Sepúlveda; Ana I López-Navas; Pedro R Gutiérrez; Pablo Ramírez; Antonio Ríos
Journal:  Transpl Int       Date:  2022-06-28       Impact factor: 3.842

4.  Advances in China's organ transplantation achieved with the guidance of law.

Authors:  Jie-Fu Huang; Hai-Bo Wang; Shu-Sen Zheng; Yong-Feng Liu; Bing-Yi Shi; Zhong-Yang Shen; Sheng-Shou Hu; Qi-Fa Ye; Wu-Jun Xue; Xiao-Shun He; Jing-Yu Chen; Feng Huo
Journal:  Chin Med J (Engl)       Date:  2015-01-20       Impact factor: 2.628

5.  Transplant Medicine in China: Need for Transparency and International Scrutiny Remains.

Authors:  T Trey; A Sharif; A Schwarz; M Fiatarone Singh; J Lavee
Journal:  Am J Transplant       Date:  2016-09-19       Impact factor: 8.086

6.  MicroRNA-146b-5p Identified in Porcine Liver Donation Model is Associated with Early Allograft Dysfunction in Human Liver Transplantation.

Authors:  Cheukfai Li; Qiang Zhao; Wei Zhang; Maogen Chen; Weiqiang Ju; Linwei Wu; Ming Han; Yi Ma; Xiaofeng Zhu; Dongping Wang; Zhiyong Guo; Xiaoshun He
Journal:  Med Sci Monit       Date:  2017-12-11

7.  Human rights violations in organ procurement practice in China.

Authors:  Norbert W Paul; Arthur Caplan; Michael E Shapiro; Charl Els; Kirk C Allison; Huige Li
Journal:  BMC Med Ethics       Date:  2017-02-08       Impact factor: 2.652

8.  Posttransplant Outcomes of Kidneys Donated After Brain Death Followed by Circulatory Death: A Cohort Study of 128 Chinese Patients.

Authors:  Ning Na; Ke Li; Zhengyu Huang; Bin Miao; Cheng Hu; Heng Li; Dejuan Wang; Jianguang Qiu
Journal:  Transplant Direct       Date:  2017-07-05

9.  Historical development and current status of organ procurement from death-row prisoners in China.

Authors:  Kirk C Allison; Arthur Caplan; Michael E Shapiro; Charl Els; Norbert W Paul; Huige Li
Journal:  BMC Med Ethics       Date:  2015-12-03       Impact factor: 2.652

10.  Forecast of the incidence, prevalence and burden of end-stage renal disease in Nanjing, China to the Year 2025.

Authors:  Ling Sun; Lu-Xi Zou; Yu-Chen Han; Han-Ming Huang; Zhao-Ming Tan; Min Gao; Kun-Ling Ma; Hong Liu; Bi-Cheng Liu
Journal:  BMC Nephrol       Date:  2016-06-13       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.